There have been many reports on the regulation of RGS2 in tumors, and the abnormal expression of RGS2 can be seen in a variety of tumors, such as colon cancer (46), ovarian cancer (47), and prostate cancer (48). This evidence concerns the gene RGS2 and ovarian carcinoma.